» Articles » PMID: 6288846

Failure of Guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to Inhibit Replication of Hepatitis A Virus in Vitro

Overview
Journal J Gen Virol
Specialty Microbiology
Date 1982 Jul 1
PMID 6288846
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Replication of hepatitis A virus (HAV) in the human hepatoma-derived PLC/PRF/5 cell line was neither inhibited in the presence of various concentrations of guanidine or D-2-(alpha-hydroxybenzyl)benzimidazole (D-HBB), nor were the two chemicals effective in combination. Under identical conditions, however, replication of poliovirus type 1 was inhibited. Tracer experiments with radiolabelled guanidine and D-HBB also furnished no evidence that the two antiviral substances were metabolized gradually to inactive derivatives in PLC/PRF/5 cells. Therefore, it is concluded that resistance to the action of guanidine and D-HBB is an inherent characteristic of HAV. However, the insensitivity of HAV to these drugs does not exclude the virus from the family of picornaviruses.

Citing Articles

Quantitative Real-Time PCR and Digital PCR to Evaluate Residual Quantity of HAV in Experimentally Depurated Mussels.

Amoroso M, Di Concilio D, Langellotti A, Martello A, Cioffi B, Suffredini E Food Environ Virol. 2021; 13(3):329-336.

PMID: 33730340 DOI: 10.1007/s12560-021-09470-4.


Molecular biology and inhibitors of hepatitis A virus.

Debing Y, Neyts J, Thibaut H Med Res Rev. 2013; 34(5):895-917.

PMID: 23722879 PMC: 7168461. DOI: 10.1002/med.21292.


Effect of ribavirin on hepatitis A virus replication in vitro.

Chaudhary R, Andonov A Can J Infect Dis. 2012; 3(2):67-70.

PMID: 22529734 PMC: 3328025. DOI: 10.1155/1992/531837.


Replication of subgenomic hepatitis A virus RNAs expressing firefly luciferase is enhanced by mutations associated with adaptation of virus to growth in cultured cells.

Yi M, Lemon S J Virol. 2002; 76(3):1171-80.

PMID: 11773393 PMC: 135777. DOI: 10.1128/jvi.76.3.1171-1180.2002.


Picornavirus inhibitors.

Carrasco L Pharmacol Ther. 1994; 64(2):215-90.

PMID: 7533301 PMC: 7133639. DOI: 10.1016/0163-7258(94)90040-x.